Cargando…
Exploring the experience of developing COVID-19 vaccines in Iran
Widespread public vaccination is one of the effective mechanisms to ensure the health and prevent deaths in societies. The coronavirus disease 2019 (COVID-19) vaccine is a stark instance in this regard. Vaccine development is a complex process requiring firm-level capabilities, various infrastructur...
Autores principales: | Ghanei, Mostafa, Mohabattalab, Ali, Fartash, Kiarash, Kolahchi, Narjes, Khakdaman, Alireza, Kaghazian, Hooman, Bagheri, Abolfazl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950226/ https://www.ncbi.nlm.nih.gov/pubmed/36844687 http://dx.doi.org/10.7774/cevr.2023.12.1.1 |
Ejemplares similares
-
National Plan for Chronic Respiratory Diseases Prevention and Control in Iran
por: Ghanei, Mostafa, et al.
Publicado: (2022) -
Prevalence of Asthma and Asthma-like Symptoms: a Study in Five Provinces of Iran
por: Sharifi, Hooman, et al.
Publicado: (2019) -
Low Levels of Extensively Drug-resistant Tuberculosis among Multidrug Resistant Tuberculosis Isolates and Their Relationship to Risk Factors: Surveillance in Tehran, Iran; 2006 to 2014
por: Tasbiti, Alireza Hadizadeh, et al.
Publicado: (2017) -
Burden of Obstructive Lung Disease in Iran: Prevalence and Risk Factors for COPD in North of Iran
por: Sharifi, Hooman, et al.
Publicado: (2020) -
Establishment of Respiratory Disease Research Network in Iran
por: Ghanei, Mostafa, et al.
Publicado: (2011)